Henry Schein, Inc. (NasdaqGS:HSIC) is looking for M&A opportunities. During the JPMorgan health care conference, Ronald South, CFO, said, "In terms of M&A, we're always -- there's always something in the pipeline that we're evaluating. where our focus has been more in the high-growth, high-margin areas of the business.
Tom mentioned a couple of the implant acquisitions we've done within the last several years. But we've also been investing more on the home solutions side in medical. We do find that to be an area of accelerated growth versus, say, core medical, and it's also an area of our business that gets better margins in our core medical.
And so we find that to be a very attractive area for M&A investment for us. And it's not restricted just to that. We are looking at on the technology side.
If we can -- if we see an opportunity to buy something, we just recently kind of folded in an imaging system process that was somebody who we had a very close relationship with, but now we've kind of captured that and it's an integral part of the offering. And along the way, we just have to make that decision. In some cases, the solution is not available out there.
It's something we may have to build ourselves on the technology side. And then there's other areas where if we feel like we can strengthen ourselves in a certain geography or within -- by getting access to a product like we've done in some of Tom's areas to broaden the product portfolio like we've done with our implant business, that's really going to be the focus. Outside of that, we still think that we've been pretty aggressive in terms of what we've done with share repurchases.
We think it brings -- it's very accretive for us right now. We think it does provide a good return to our shareholders. And as long as we can generate the positive cash flow that we've been able to do, we'll continue to be aggressive there as well".
